EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ER22 / 23EK polymorphisms of the glucocorticoid receptor are not associated with the response of alcohol‐associated hepatitis patients to prednisolone treatment

Navakanth Raju Ramayanam, Rajesh Nanda Amarnath, Sarad Pawar Naik Buke, Vijayakumar Thangavelmahalingam, Abdullateef Isiaka Alagbonsi iD, Hope Onohuean iD

Physiological Reports · 2026-11 · 14 (21)

DOI: 10.14814/phy2.71163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiological Reports, online erschienen am 08.11.2026. Verfasst von Navakanth Raju Ramayanam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Faculty of Pharmacy, Dr. M.G.R. Educational and Research Institute, Chennai, Tamil Nadu, India. Hauptthemen laut MEDLINE: Receptors, Glucocorticoid, Prednisolone, Hepatitis, Alcoholic, Glucocorticoids. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effects of prednisolone on biochemical parameters in patients with alcohol‐associated hepatitis (AH) have been reported. However, data on the pharmacogenetic determinants of prednisolone response in these patients remain limited. Because the ER22/23EK polymorphism of the glucocorticoid receptor gene (NR3C1) has been linked with relative glucocorticoid resistance in other settings, this study investigated its prevalence and influence among prednisolone‐responsive and non‐responsive AH patients. A total of 134 patients with AH were enrolled in this prospective study. Biochemical parameters diagnostic of liver function, messenger ribonucleic acid (mRNA) expression of tumor necrosis factor‐alpha (TNF‐α), and ER22/23EK (rs6189 and rs6190) genotypes were assessed. Prednisolone response was defined using the Lille score after 7 days of therapy. Beyond classical biochemical parameters of liver function and the Lille score, ER22/23EK genotype polymorphisms of the glucocorticoid receptor were not associated with patients' response to prednisolone treatment in this cohort. TNF‐α mRNA expression was higher in AH patients who responded to prednisolone than in those who did not respond to treatment. TNF‐α mRNA was higher at day 7 among prednisolone responders than non‐responders. More importantly, in this cohort, prednisolone response among AH patients was not statistically associated with the ER22/23EK genotype. These findings should be interpreted cautiously because additional glucocorticoid receptor targets, 11β‐hydroxysteroid dehydrogenase expression, and functional GR assays were not assessed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, GlucocorticoidPrednisoloneHepatitis, AlcoholicGlucocorticoidsHumansMaleFemaleTumor Necrosis Factor-alphaMiddle AgedPolymorphism, Single NucleotideAdultProspective StudiesAged

Stichwörter der Autor:innen

ER22/23EKLille scorealcohol‐associated hepatitisglucocorticoid receptorpharmacogeneticsprednisolonetumor necrosis factor‐alpha

Substanzen

Receptors, GlucocorticoidPrednisoloneTumor Necrosis Factor-alphaGlucocorticoidsNR3C1 protein, human

Autor:innen und Institutionen

  • Department of Pharmacy Practice, Faculty of Pharmacy, Dr. M.G.R. Educational and Research Institute, Chennai, Tamil Nadu, India.
  • Department of Medical Gastroenterology, SRM Medical College Hospital and Research Center, Kattankulathur, Kanchipuram, Tamil Nadu, India.
  • Department of Pharmacy, Faculty of Health Sciences, Victoria University, Kampala, Uganda.
  • Department of Pharmacy Practice, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Kanchipuram, Tamil Nadu, India.
  • Department of Physiology, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Huye, Southern Province, Republic of Rwanda.
  • Biomolecules, Metagenomics, Endocrine and Tropical Disease Research Group (BMETDREG), Kampala International University, Western Campus, Bushenyi, Uganda.

ORCID-Profile: Abdullateef Isiaka Alagbonsi, Hope Onohuean

Zitieren

APA

Ramayanam, N. R., Amarnath, R. N., Buke, S. P. N., Thangavelmahalingam, V., Alagbonsi, A. I., & Onohuean, H. (2026). ER22 / 23EK polymorphisms of the glucocorticoid receptor are not associated with the response of alcohol‐associated hepatitis patients to prednisolone treatment. Physiological Reports, 14(21). https://doi.org/10.14814/phy2.71163

Vancouver

Ramayanam NR, Amarnath RN, Buke SPN, Thangavelmahalingam V, Alagbonsi AI, Onohuean H. ER22 / 23EK polymorphisms of the glucocorticoid receptor are not associated with the response of alcohol‐associated hepatitis patients to prednisolone treatment. Physiological Reports. 2026;14(21). doi:10.14814/phy2.71163

BibTeX
@article{Ramayanam2026,
  author = {Ramayanam, Navakanth Raju and Amarnath, Rajesh Nanda and Buke, Sarad Pawar Naik and Thangavelmahalingam, Vijayakumar and Alagbonsi, Abdullateef Isiaka and Onohuean, Hope},
  title = {ER22 / 23EK polymorphisms of the glucocorticoid receptor are not associated with the response of alcohol‐associated hepatitis patients to prednisolone treatment},
  journal = {Physiological Reports},
  year = {2026},
  volume = {14},
  number = {21},
  doi = {10.14814/phy2.71163}
}
Kostenlos starten →